| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glycoproteins | 19 | 2022 | 375 | 4.210 |
Why?
|
| Kidney | 30 | 2025 | 1331 | 2.820 |
Why?
|
| Acute Kidney Injury | 10 | 2025 | 672 | 1.680 |
Why?
|
| Nephritis, Interstitial | 2 | 2023 | 40 | 1.520 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-2 | 3 | 2024 | 16 | 1.360 |
Why?
|
| Mitochondria | 7 | 2022 | 747 | 1.320 |
Why?
|
| Superoxides | 8 | 2021 | 133 | 1.130 |
Why?
|
| Ischemic Preconditioning | 2 | 2015 | 22 | 0.930 |
Why?
|
| Reperfusion Injury | 3 | 2021 | 110 | 0.920 |
Why?
|
| Ion Channels | 7 | 2014 | 207 | 0.920 |
Why?
|
| Hypertonic Solutions | 7 | 2006 | 20 | 0.920 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2023 | 845 | 0.920 |
Why?
|
| Mitochondrial Proteins | 6 | 2014 | 260 | 0.880 |
Why?
|
| Mitogen-Activated Protein Kinases | 7 | 2004 | 200 | 0.820 |
Why?
|
| Cisplatin | 5 | 2025 | 281 | 0.750 |
Why?
|
| Protein Sorting Signals | 1 | 2022 | 41 | 0.740 |
Why?
|
| Gluconeogenesis | 1 | 2021 | 96 | 0.690 |
Why?
|
| Signal Transduction | 10 | 2019 | 4703 | 0.680 |
Why?
|
| Animals | 52 | 2025 | 34881 | 0.680 |
Why?
|
| Lactic Acid | 1 | 2021 | 156 | 0.660 |
Why?
|
| Renal Insufficiency | 2 | 2022 | 256 | 0.640 |
Why?
|
| Glomerular Mesangium | 3 | 2021 | 19 | 0.640 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2020 | 1176 | 0.590 |
Why?
|
| Antioxidants | 2 | 2012 | 333 | 0.570 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2018 | 50 | 0.560 |
Why?
|
| Mice | 25 | 2025 | 18507 | 0.560 |
Why?
|
| Cell Line | 15 | 2025 | 2719 | 0.560 |
Why?
|
| Ureteral Obstruction | 6 | 2004 | 105 | 0.540 |
Why?
|
| Macrophages | 5 | 2025 | 689 | 0.530 |
Why?
|
| Kidney Diseases | 3 | 2025 | 489 | 0.530 |
Why?
|
| Mice, Transgenic | 9 | 2020 | 2445 | 0.530 |
Why?
|
| Membrane Glycoproteins | 5 | 2009 | 420 | 0.520 |
Why?
|
| Transforming Growth Factor beta | 4 | 2018 | 473 | 0.510 |
Why?
|
| Amyloid beta-Peptides | 1 | 2018 | 226 | 0.500 |
Why?
|
| Apoptosis | 10 | 2024 | 1892 | 0.500 |
Why?
|
| Mice, Inbred C57BL | 14 | 2022 | 4757 | 0.490 |
Why?
|
| Angiotensin II | 4 | 2012 | 163 | 0.480 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2025 | 305 | 0.480 |
Why?
|
| Nephritis | 1 | 2015 | 20 | 0.480 |
Why?
|
| Thrombin | 1 | 2015 | 60 | 0.470 |
Why?
|
| Lung Injury | 1 | 2015 | 123 | 0.430 |
Why?
|
| Macrophages, Peritoneal | 2 | 2016 | 39 | 0.430 |
Why?
|
| Kidney Tubules | 6 | 2020 | 74 | 0.430 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 6 | 2022 | 126 | 0.430 |
Why?
|
| Sirtuin 3 | 3 | 2021 | 30 | 0.420 |
Why?
|
| Postoperative Complications | 3 | 2020 | 3142 | 0.420 |
Why?
|
| Smad3 Protein | 1 | 2013 | 57 | 0.410 |
Why?
|
| Inflammation Mediators | 3 | 2016 | 240 | 0.410 |
Why?
|
| Gene Expression Regulation | 8 | 2019 | 2438 | 0.400 |
Why?
|
| Agrochemicals | 2 | 2023 | 13 | 0.400 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 101 | 0.400 |
Why?
|
| Myocytes, Cardiac | 2 | 2012 | 660 | 0.400 |
Why?
|
| Cytoprotection | 2 | 2010 | 38 | 0.390 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2014 | 175 | 0.390 |
Why?
|
| RNA, Messenger | 15 | 2017 | 2674 | 0.390 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 2 | 2009 | 8 | 0.380 |
Why?
|
| Fibrosis | 3 | 2013 | 423 | 0.380 |
Why?
|
| Up-Regulation | 6 | 2019 | 876 | 0.380 |
Why?
|
| Receptors, Ghrelin | 3 | 2018 | 30 | 0.380 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 201 | 0.380 |
Why?
|
| Collagen | 1 | 2013 | 308 | 0.370 |
Why?
|
| Glomerulonephritis, IGA | 2 | 2021 | 17 | 0.350 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 445 | 0.340 |
Why?
|
| Hormones | 2 | 2003 | 170 | 0.340 |
Why?
|
| Rats | 14 | 2025 | 3611 | 0.330 |
Why?
|
| Reactive Oxygen Species | 6 | 2021 | 518 | 0.320 |
Why?
|
| Male | 35 | 2025 | 64920 | 0.310 |
Why?
|
| Nanoparticles | 2 | 2025 | 290 | 0.310 |
Why?
|
| Endothelium | 1 | 2009 | 64 | 0.310 |
Why?
|
| Integrin beta1 | 2 | 2000 | 56 | 0.300 |
Why?
|
| NADPH Oxidases | 1 | 2009 | 111 | 0.300 |
Why?
|
| Water-Electrolyte Balance | 3 | 2004 | 82 | 0.300 |
Why?
|
| Paraquat | 2 | 2022 | 14 | 0.290 |
Why?
|
| Dogs | 8 | 2006 | 657 | 0.290 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2025 | 1222 | 0.290 |
Why?
|
| Uncoupling Protein 2 | 3 | 2014 | 13 | 0.290 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 105 | 0.280 |
Why?
|
| Renal Dialysis | 5 | 2019 | 948 | 0.280 |
Why?
|
| Antihypertensive Agents | 2 | 2017 | 429 | 0.280 |
Why?
|
| Cell Nucleus | 2 | 2008 | 587 | 0.270 |
Why?
|
| HEK293 Cells | 2 | 2022 | 799 | 0.270 |
Why?
|
| Catheters, Indwelling | 2 | 1998 | 157 | 0.270 |
Why?
|
| Uncompensated Care | 1 | 2007 | 12 | 0.260 |
Why?
|
| Cytoplasm | 1 | 2008 | 268 | 0.260 |
Why?
|
| Humans | 41 | 2025 | 132061 | 0.260 |
Why?
|
| Emigration and Immigration | 1 | 2007 | 83 | 0.250 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2006 | 9 | 0.250 |
Why?
|
| Antigens, CD | 2 | 2000 | 431 | 0.250 |
Why?
|
| Contrast Media | 1 | 2010 | 508 | 0.250 |
Why?
|
| Polyesters | 1 | 2025 | 41 | 0.230 |
Why?
|
| Calcium | 4 | 2006 | 1078 | 0.230 |
Why?
|
| Aging | 3 | 2018 | 1250 | 0.230 |
Why?
|
| Kidney Failure, Chronic | 4 | 2019 | 951 | 0.220 |
Why?
|
| Hydroxyurea | 1 | 2025 | 85 | 0.220 |
Why?
|
| Hydrogen Peroxide | 2 | 2015 | 124 | 0.220 |
Why?
|
| Oxidative Stress | 3 | 2024 | 803 | 0.210 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2004 | 50 | 0.210 |
Why?
|
| Calcium Channel Blockers | 2 | 2008 | 118 | 0.210 |
Why?
|
| Tetrazoles | 1 | 2004 | 69 | 0.210 |
Why?
|
| Trans-Activators | 2 | 2005 | 712 | 0.210 |
Why?
|
| Chemotaxis | 1 | 2003 | 62 | 0.210 |
Why?
|
| Polymyxin B | 1 | 2024 | 47 | 0.210 |
Why?
|
| Health Care Costs | 1 | 2007 | 412 | 0.210 |
Why?
|
| Acetylcysteine | 2 | 2010 | 82 | 0.200 |
Why?
|
| Thrombosis | 2 | 1998 | 524 | 0.200 |
Why?
|
| Benzimidazoles | 1 | 2004 | 132 | 0.200 |
Why?
|
| Calcium Channels, L-Type | 1 | 2003 | 52 | 0.200 |
Why?
|
| Anti-Bacterial Agents | 2 | 2025 | 2558 | 0.200 |
Why?
|
| Cations | 1 | 2022 | 37 | 0.190 |
Why?
|
| MAP Kinase Signaling System | 2 | 2015 | 309 | 0.190 |
Why?
|
| Uric Acid | 2 | 2003 | 110 | 0.190 |
Why?
|
| Female | 17 | 2023 | 70710 | 0.190 |
Why?
|
| Mice, Knockout | 7 | 2019 | 3863 | 0.180 |
Why?
|
| Kidney Medulla | 5 | 2003 | 19 | 0.180 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2022 | 145 | 0.180 |
Why?
|
| Diabetic Nephropathies | 1 | 2022 | 115 | 0.180 |
Why?
|
| Cell Membrane | 4 | 2018 | 470 | 0.180 |
Why?
|
| DNA-Binding Proteins | 3 | 2005 | 1977 | 0.180 |
Why?
|
| Cytokines | 3 | 2015 | 1358 | 0.180 |
Why?
|
| Cyclosporine | 1 | 2001 | 126 | 0.170 |
Why?
|
| Complement C1q | 1 | 2021 | 18 | 0.170 |
Why?
|
| RAW 264.7 Cells | 2 | 2018 | 46 | 0.170 |
Why?
|
| Proteinuria | 2 | 2018 | 110 | 0.170 |
Why?
|
| Leucine | 1 | 2022 | 260 | 0.170 |
Why?
|
| Immunohistochemistry | 6 | 2009 | 1694 | 0.170 |
Why?
|
| Loop of Henle | 1 | 2000 | 4 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2008 | 93 | 0.170 |
Why?
|
| Betaine | 2 | 1998 | 21 | 0.170 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 1347 | 0.170 |
Why?
|
| Hyperglycemia | 1 | 2022 | 235 | 0.170 |
Why?
|
| Transcription Factors | 3 | 2006 | 2493 | 0.170 |
Why?
|
| Creatinine | 3 | 2025 | 412 | 0.170 |
Why?
|
| Extracellular Space | 1 | 2000 | 85 | 0.160 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2020 | 38 | 0.160 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2020 | 25 | 0.160 |
Why?
|
| Adaptation, Physiological | 1 | 2001 | 271 | 0.160 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 118 | 0.160 |
Why?
|
| Adenosine Triphosphate | 2 | 2012 | 275 | 0.160 |
Why?
|
| Coumarins | 1 | 2019 | 23 | 0.160 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 4688 | 0.150 |
Why?
|
| Fever | 2 | 1998 | 311 | 0.150 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 1998 | 7 | 0.150 |
Why?
|
| Diabetes Insipidus | 1 | 1998 | 16 | 0.150 |
Why?
|
| Blotting, Western | 4 | 2017 | 1077 | 0.150 |
Why?
|
| Equipment Reuse | 1 | 1998 | 7 | 0.150 |
Why?
|
| Sp Transcription Factors | 2 | 2009 | 2 | 0.150 |
Why?
|
| Ghrelin | 2 | 2018 | 56 | 0.150 |
Why?
|
| Retinopathy of Prematurity | 1 | 2019 | 64 | 0.150 |
Why?
|
| Renal Tubular Transport, Inborn Errors | 1 | 2018 | 4 | 0.150 |
Why?
|
| Oculocerebrorenal Syndrome | 1 | 2018 | 8 | 0.150 |
Why?
|
| Thermogenesis | 2 | 2018 | 51 | 0.150 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2018 | 34 | 0.140 |
Why?
|
| Polytetrafluoroethylene | 1 | 1998 | 67 | 0.140 |
Why?
|
| Caspases | 4 | 2003 | 165 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2015 | 294 | 0.140 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1999 | 230 | 0.140 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2018 | 44 | 0.140 |
Why?
|
| Myocardium | 1 | 2003 | 908 | 0.140 |
Why?
|
| Hyperkalemia | 1 | 2019 | 71 | 0.140 |
Why?
|
| Models, Animal | 2 | 2014 | 470 | 0.140 |
Why?
|
| Hot Temperature | 2 | 1998 | 141 | 0.140 |
Why?
|
| Carrier Proteins | 5 | 2000 | 1047 | 0.140 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1998 | 74 | 0.140 |
Why?
|
| Necrosis | 3 | 2009 | 209 | 0.140 |
Why?
|
| Integrases | 1 | 2018 | 158 | 0.130 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1999 | 291 | 0.130 |
Why?
|
| Prostaglandins F, Synthetic | 1 | 2017 | 3 | 0.130 |
Why?
|
| Free Radical Scavengers | 1 | 1997 | 58 | 0.130 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 672 | 0.130 |
Why?
|
| Coronary Angiography | 1 | 2020 | 485 | 0.130 |
Why?
|
| Myopia | 1 | 2018 | 133 | 0.130 |
Why?
|
| Metabolomics | 2 | 2018 | 480 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 397 | 0.130 |
Why?
|
| Adiposity | 1 | 2018 | 207 | 0.130 |
Why?
|
| Osmolar Concentration | 3 | 2004 | 157 | 0.130 |
Why?
|
| Quality of Life | 1 | 2007 | 2137 | 0.130 |
Why?
|
| Stress, Physiological | 2 | 2019 | 260 | 0.130 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2018 | 156 | 0.130 |
Why?
|
| Extreme Heat | 1 | 2016 | 1 | 0.130 |
Why?
|
| Heat Stress Disorders | 1 | 2016 | 10 | 0.130 |
Why?
|
| Intraocular Pressure | 1 | 2017 | 135 | 0.130 |
Why?
|
| Chemokine CXCL16 | 1 | 2015 | 5 | 0.120 |
Why?
|
| Chemokine CXCL6 | 1 | 2015 | 10 | 0.120 |
Why?
|
| Insulin Resistance | 2 | 2018 | 697 | 0.120 |
Why?
|
| Panniculitis | 1 | 2016 | 19 | 0.120 |
Why?
|
| Cells, Cultured | 5 | 2019 | 3036 | 0.120 |
Why?
|
| Cell Movement | 3 | 2009 | 889 | 0.120 |
Why?
|
| Epidemics | 1 | 2016 | 59 | 0.120 |
Why?
|
| Gene Expression | 3 | 2001 | 1558 | 0.120 |
Why?
|
| Osteopontin | 1 | 2015 | 52 | 0.120 |
Why?
|
| Protective Agents | 1 | 2015 | 36 | 0.120 |
Why?
|
| Bleomycin | 1 | 2015 | 113 | 0.120 |
Why?
|
| Intra-Abdominal Fat | 1 | 2016 | 61 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2018 | 792 | 0.120 |
Why?
|
| Climate Change | 1 | 2016 | 63 | 0.120 |
Why?
|
| Albumins | 1 | 2015 | 95 | 0.120 |
Why?
|
| Chemokines | 1 | 2015 | 129 | 0.120 |
Why?
|
| Transcription, Genetic | 3 | 2009 | 1422 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 1998 | 323 | 0.110 |
Why?
|
| Phosphorylation | 3 | 2015 | 1608 | 0.110 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 142 | 0.110 |
Why?
|
| Calcium Oxalate | 2 | 2005 | 24 | 0.110 |
Why?
|
| Antibodies | 1 | 2015 | 364 | 0.110 |
Why?
|
| Inflammation | 3 | 2025 | 1517 | 0.110 |
Why?
|
| Uncoupling Protein 1 | 2 | 2014 | 32 | 0.110 |
Why?
|
| Unfolded Protein Response | 1 | 2014 | 65 | 0.110 |
Why?
|
| Proteins | 2 | 2018 | 1036 | 0.110 |
Why?
|
| Base Sequence | 4 | 2000 | 2899 | 0.100 |
Why?
|
| Risk Factors | 2 | 2023 | 10941 | 0.100 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2024 | 74 | 0.100 |
Why?
|
| Staphylococcal Infections | 1 | 1998 | 569 | 0.100 |
Why?
|
| Electrocardiography | 1 | 2019 | 1014 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3761 | 0.100 |
Why?
|
| Actins | 1 | 2015 | 334 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 2 | 2004 | 21 | 0.100 |
Why?
|
| Shock | 1 | 1994 | 98 | 0.100 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2018 | 426 | 0.100 |
Why?
|
| Chemokine CCL2 | 2 | 2003 | 118 | 0.100 |
Why?
|
| ortho-Aminobenzoates | 2 | 2009 | 6 | 0.100 |
Why?
|
| Uncoupling Protein 3 | 1 | 2012 | 7 | 0.100 |
Why?
|
| Heat-Shock Proteins | 3 | 2001 | 183 | 0.100 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 806 | 0.090 |
Why?
|
| Capillary Permeability | 1 | 2012 | 76 | 0.090 |
Why?
|
| Pneumonia | 1 | 2015 | 334 | 0.090 |
Why?
|
| Transfection | 3 | 2014 | 996 | 0.090 |
Why?
|
| Dopamine | 1 | 1993 | 253 | 0.090 |
Why?
|
| Time Factors | 6 | 2014 | 6448 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2003 | 238 | 0.090 |
Why?
|
| Coronary Vessels | 2 | 2008 | 550 | 0.090 |
Why?
|
| Phenotype | 3 | 2016 | 4529 | 0.090 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 1824 | 0.090 |
Why?
|
| Osmotic Pressure | 2 | 2001 | 24 | 0.090 |
Why?
|
| Genotype | 2 | 2014 | 2697 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 1170 | 0.090 |
Why?
|
| T-Lymphocytes | 2 | 2012 | 1738 | 0.090 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 3091 | 0.080 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 898 | 0.080 |
Why?
|
| Autophagy | 1 | 2014 | 426 | 0.080 |
Why?
|
| Nephrotic Syndrome | 2 | 2003 | 51 | 0.080 |
Why?
|
| Liver | 1 | 2017 | 1797 | 0.080 |
Why?
|
| Hemofiltration | 1 | 2010 | 11 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2009 | 29 | 0.080 |
Why?
|
| Heart Failure | 1 | 2003 | 2393 | 0.080 |
Why?
|
| Sodium Bicarbonate | 1 | 2010 | 56 | 0.080 |
Why?
|
| NADPH Oxidase 2 | 1 | 2009 | 38 | 0.080 |
Why?
|
| Tissue Distribution | 2 | 2000 | 383 | 0.080 |
Why?
|
| Electron Transport | 1 | 2009 | 57 | 0.080 |
Why?
|
| Glomerular Basement Membrane | 1 | 2009 | 9 | 0.080 |
Why?
|
| Permeability | 1 | 2009 | 122 | 0.080 |
Why?
|
| G1 Phase | 1 | 2009 | 66 | 0.080 |
Why?
|
| Sodium | 3 | 1998 | 295 | 0.080 |
Why?
|
| Glomerulonephritis | 1 | 2009 | 75 | 0.070 |
Why?
|
| Adult | 10 | 2021 | 31567 | 0.070 |
Why?
|
| NF-kappa B | 3 | 2025 | 454 | 0.070 |
Why?
|
| Fluid Therapy | 1 | 2010 | 147 | 0.070 |
Why?
|
| Molecular Sequence Data | 3 | 2000 | 3770 | 0.070 |
Why?
|
| Autoantigens | 1 | 2009 | 106 | 0.070 |
Why?
|
| Kidney Function Tests | 1 | 2009 | 138 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2009 | 422 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2008 | 51 | 0.070 |
Why?
|
| Protein Transport | 1 | 2009 | 369 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2021 | 1131 | 0.070 |
Why?
|
| Cell Membrane Permeability | 1 | 2008 | 72 | 0.070 |
Why?
|
| Middle Aged | 9 | 2020 | 28964 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2014 | 677 | 0.070 |
Why?
|
| Culture Media | 2 | 2000 | 183 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2008 | 664 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 450 | 0.070 |
Why?
|
| Lipolysis | 2 | 2018 | 75 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2007 | 46 | 0.060 |
Why?
|
| Acute Disease | 1 | 2010 | 1160 | 0.060 |
Why?
|
| MAP Kinase Kinase Kinase 4 | 1 | 2006 | 2 | 0.060 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 2 | 1998 | 9 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2009 | 990 | 0.060 |
Why?
|
| Prognosis | 3 | 2021 | 5009 | 0.060 |
Why?
|
| Enzyme Activation | 3 | 2003 | 615 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2007 | 109 | 0.060 |
Why?
|
| Cell Survival | 2 | 2024 | 865 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 1294 | 0.060 |
Why?
|
| Brain | 1 | 2018 | 3183 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2020 | 3736 | 0.060 |
Why?
|
| Pyridines | 2 | 2017 | 249 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 662 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2006 | 163 | 0.060 |
Why?
|
| Autoantibodies | 1 | 2009 | 456 | 0.060 |
Why?
|
| Epithelium | 2 | 1997 | 354 | 0.060 |
Why?
|
| Flavanones | 1 | 2025 | 8 | 0.060 |
Why?
|
| Stress, Mechanical | 1 | 2006 | 173 | 0.060 |
Why?
|
| Enzyme Inhibitors | 2 | 1999 | 588 | 0.060 |
Why?
|
| Isoenzymes | 2 | 2003 | 223 | 0.060 |
Why?
|
| Amikacin | 1 | 2025 | 26 | 0.060 |
Why?
|
| Kidney Concentrating Ability | 1 | 2004 | 16 | 0.060 |
Why?
|
| Ultrasonics | 1 | 2005 | 37 | 0.060 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2005 | 40 | 0.060 |
Why?
|
| Rabbits | 3 | 1996 | 688 | 0.060 |
Why?
|
| Aged | 6 | 2020 | 21406 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2025 | 140 | 0.050 |
Why?
|
| Cell Division | 2 | 2003 | 743 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2008 | 527 | 0.050 |
Why?
|
| Insulin | 2 | 2022 | 1168 | 0.050 |
Why?
|
| Smad2 Protein | 1 | 2004 | 53 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 576 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2024 | 67 | 0.050 |
Why?
|
| Biphenyl Compounds | 1 | 2004 | 56 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 687 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2025 | 225 | 0.050 |
Why?
|
| U937 Cells | 1 | 2003 | 23 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 1284 | 0.050 |
Why?
|
| Platinum | 1 | 2003 | 13 | 0.050 |
Why?
|
| Thrombophlebitis | 1 | 1983 | 19 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2006 | 487 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 124 | 0.050 |
Why?
|
| Lidocaine | 1 | 1983 | 45 | 0.050 |
Why?
|
| Calcinosis | 1 | 2005 | 192 | 0.050 |
Why?
|
| Vancomycin | 1 | 2025 | 222 | 0.050 |
Why?
|
| Nimodipine | 1 | 2003 | 6 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2021 | 6567 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 1044 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2005 | 346 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 68 | 0.050 |
Why?
|
| Genes, p53 | 2 | 2001 | 221 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2003 | 301 | 0.050 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2003 | 51 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 82 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 177 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 1301 | 0.050 |
Why?
|
| Child | 1 | 2023 | 25789 | 0.050 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2005 | 240 | 0.050 |
Why?
|
| Biological Transport | 2 | 2001 | 349 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 1983 | 226 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2007 | 418 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 273 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2003 | 468 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2003 | 89 | 0.050 |
Why?
|
| Heparin | 1 | 1983 | 212 | 0.050 |
Why?
|
| Amyloidosis | 1 | 2003 | 74 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 416 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 2057 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2003 | 255 | 0.050 |
Why?
|
| NFATC Transcription Factors | 1 | 2001 | 38 | 0.050 |
Why?
|
| Response Elements | 1 | 2001 | 98 | 0.040 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2000 | 13 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2007 | 729 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 2005 | 447 | 0.040 |
Why?
|
| Membranes | 1 | 2000 | 17 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2000 | 77 | 0.040 |
Why?
|
| fas Receptor | 1 | 2000 | 47 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2004 | 559 | 0.040 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2000 | 16 | 0.040 |
Why?
|
| Body Water | 1 | 2000 | 88 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2021 | 216 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1999 | 63 | 0.040 |
Why?
|
| Aldehyde Reductase | 1 | 1999 | 17 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 1538 | 0.040 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 1999 | 44 | 0.040 |
Why?
|
| Podocytes | 1 | 2020 | 77 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2003 | 551 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2021 | 327 | 0.040 |
Why?
|
| Natriuresis | 1 | 1998 | 20 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2004 | 570 | 0.040 |
Why?
|
| Polyuria | 1 | 1998 | 10 | 0.040 |
Why?
|
| Homeostasis | 1 | 2003 | 721 | 0.040 |
Why?
|
| Antidiuretic Hormone Receptor Antagonists | 1 | 1998 | 5 | 0.040 |
Why?
|
| Carbohydrates | 1 | 2018 | 39 | 0.040 |
Why?
|
| Estradiol | 1 | 2021 | 487 | 0.040 |
Why?
|
| Aquaporins | 1 | 1998 | 18 | 0.040 |
Why?
|
| Indium Radioisotopes | 1 | 1998 | 7 | 0.040 |
Why?
|
| Flavonoids | 1 | 1999 | 86 | 0.040 |
Why?
|
| Diuresis | 1 | 1998 | 46 | 0.040 |
Why?
|
| Age Factors | 2 | 2016 | 2912 | 0.040 |
Why?
|
| Texas | 1 | 2007 | 3629 | 0.040 |
Why?
|
| DNA Primers | 1 | 1999 | 636 | 0.040 |
Why?
|
| Benzazepines | 1 | 1998 | 48 | 0.040 |
Why?
|
| Growth Hormone | 1 | 2018 | 129 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2022 | 763 | 0.040 |
Why?
|
| Microvilli | 3 | 1993 | 69 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2018 | 87 | 0.040 |
Why?
|
| Escherichia coli Proteins | 1 | 2000 | 316 | 0.030 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 1997 | 19 | 0.030 |
Why?
|
| Adipose Tissue, White | 1 | 2018 | 94 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2018 | 207 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2021 | 17419 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 1998 | 126 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 1998 | 173 | 0.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1998 | 87 | 0.030 |
Why?
|
| Kidney Glomerulus | 1 | 1997 | 81 | 0.030 |
Why?
|
| Vero Cells | 1 | 1997 | 113 | 0.030 |
Why?
|
| Ocular Hypotension | 1 | 2017 | 4 | 0.030 |
Why?
|
| Tonometry, Ocular | 1 | 2017 | 30 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2019 | 698 | 0.030 |
Why?
|
| Endocarditis, Bacterial | 1 | 1998 | 136 | 0.030 |
Why?
|
| Anterior Eye Segment | 1 | 2017 | 25 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2017 | 136 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1997 | 79 | 0.030 |
Why?
|
| Drug Overdose | 1 | 1997 | 74 | 0.030 |
Why?
|
| Reference Values | 1 | 1998 | 708 | 0.030 |
Why?
|
| Amides | 1 | 2017 | 91 | 0.030 |
Why?
|
| rho-Associated Kinases | 1 | 2017 | 51 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2020 | 1253 | 0.030 |
Why?
|
| Sri Lanka | 1 | 2016 | 11 | 0.030 |
Why?
|
| Central America | 1 | 2016 | 20 | 0.030 |
Why?
|
| South America | 1 | 2016 | 42 | 0.030 |
Why?
|
| Imidazoles | 1 | 1998 | 219 | 0.030 |
Why?
|
| Physical Exertion | 1 | 2016 | 73 | 0.030 |
Why?
|
| Dehydration | 1 | 2016 | 41 | 0.030 |
Why?
|
| Eating | 1 | 2018 | 381 | 0.030 |
Why?
|
| Phospholipases A2 | 2 | 1993 | 36 | 0.030 |
Why?
|
| Graft Survival | 1 | 1998 | 474 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2020 | 523 | 0.030 |
Why?
|
| Phospholipases A | 2 | 1993 | 36 | 0.030 |
Why?
|
| Hormone Antagonists | 1 | 2016 | 49 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1996 | 29 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2019 | 1035 | 0.030 |
Why?
|
| Oxygen | 1 | 2019 | 572 | 0.030 |
Why?
|
| India | 1 | 2016 | 238 | 0.030 |
Why?
|
| North America | 1 | 2016 | 264 | 0.030 |
Why?
|
| Cell Plasticity | 1 | 2016 | 36 | 0.030 |
Why?
|
| Testosterone | 1 | 2021 | 611 | 0.030 |
Why?
|
| Critical Illness | 1 | 2020 | 618 | 0.030 |
Why?
|
| Medication Errors | 1 | 1997 | 205 | 0.030 |
Why?
|
| Protein Binding | 1 | 1999 | 1729 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 540 | 0.030 |
Why?
|
| Adipocytes, Brown | 1 | 2014 | 28 | 0.030 |
Why?
|
| Osmosis | 1 | 1994 | 17 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2224 | 0.030 |
Why?
|
| Norepinephrine | 1 | 2014 | 166 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 573 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 306 | 0.030 |
Why?
|
| Peptide Hormones | 1 | 2014 | 71 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2010 | 13028 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 1028 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2018 | 785 | 0.030 |
Why?
|
| Type C Phospholipases | 1 | 1993 | 21 | 0.030 |
Why?
|
| Receptors, Angiotensin | 1 | 1993 | 20 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 2320 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 1993 | 75 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 1998 | 1952 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 514 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 1997 | 460 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2019 | 918 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 1993 | 234 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1993 | 246 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 1548 | 0.020 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 1993 | 137 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 1996 | 903 | 0.020 |
Why?
|
| Fas Ligand Protein | 2 | 2001 | 36 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2009 | 3681 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3406 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 1989 | 58 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1989 | 219 | 0.020 |
Why?
|
| Hypertension | 2 | 2005 | 1396 | 0.020 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2008 | 17 | 0.020 |
Why?
|
| Claudin-1 | 1 | 2008 | 19 | 0.020 |
Why?
|
| Nifedipine | 1 | 2008 | 22 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2008 | 36 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 361 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2007 | 7 | 0.020 |
Why?
|
| Sp4 Transcription Factor | 1 | 2007 | 4 | 0.020 |
Why?
|
| Sp3 Transcription Factor | 1 | 2007 | 7 | 0.020 |
Why?
|
| Sp1 Transcription Factor | 1 | 2007 | 42 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 9956 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 7102 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2008 | 442 | 0.010 |
Why?
|
| Smad7 Protein | 1 | 2005 | 5 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 444 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2007 | 662 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2005 | 249 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3350 | 0.010 |
Why?
|
| Nafronyl | 1 | 2004 | 1 | 0.010 |
Why?
|
| Absorption | 1 | 2004 | 51 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 196 | 0.010 |
Why?
|
| Oxalates | 1 | 2004 | 22 | 0.010 |
Why?
|
| Doxycycline | 1 | 2005 | 120 | 0.010 |
Why?
|
| Cadaver | 1 | 2004 | 119 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2005 | 178 | 0.010 |
Why?
|
| Transgenes | 1 | 2005 | 335 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1983 | 79 | 0.010 |
Why?
|
| Living Donors | 1 | 2004 | 116 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 1280 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2004 | 207 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 2003 | 110 | 0.010 |
Why?
|
| United States | 1 | 1998 | 11658 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 129 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2004 | 652 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2009 | 2508 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2003 | 435 | 0.010 |
Why?
|
| Genes, bcl-2 | 1 | 2001 | 9 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2005 | 925 | 0.010 |
Why?
|
| TNF Receptor-Associated Death Domain Protein | 1 | 2000 | 3 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2000 | 5 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 1 | 2000 | 9 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2000 | 23 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2000 | 25 | 0.010 |
Why?
|
| Coenzyme A Ligases | 1 | 2000 | 12 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2000 | 44 | 0.010 |
Why?
|
| Atrophy | 1 | 2001 | 252 | 0.010 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2000 | 19 | 0.010 |
Why?
|
| Biopsy | 1 | 2004 | 1284 | 0.010 |
Why?
|
| Sodium-Hydrogen Exchangers | 2 | 1991 | 30 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2000 | 77 | 0.010 |
Why?
|
| Organ Size | 1 | 2001 | 449 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2000 | 76 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2008 | 1610 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2000 | 169 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2005 | 1400 | 0.010 |
Why?
|
| Clusterin | 1 | 1998 | 11 | 0.010 |
Why?
|
| Aquaporin 6 | 1 | 1998 | 2 | 0.010 |
Why?
|
| Aquaporin 2 | 1 | 1998 | 6 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1998 | 22 | 0.010 |
Why?
|
| Kidney Tubules, Collecting | 1 | 1998 | 7 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1998 | 45 | 0.010 |
Why?
|
| Thirst | 1 | 1998 | 5 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1998 | 90 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2000 | 573 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 329 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 1997 | 125 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 2172 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2000 | 624 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2005 | 1658 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2000 | 1234 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 1983 | 1048 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 930 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1997 | 855 | 0.010 |
Why?
|
| Sodium Radioisotopes | 1 | 1991 | 1 | 0.010 |
Why?
|
| Melitten | 1 | 1991 | 3 | 0.010 |
Why?
|
| Arachidonic Acids | 1 | 1991 | 29 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1991 | 172 | 0.010 |
Why?
|
| Sodium, Dietary | 1 | 1989 | 37 | 0.000 |
Why?
|
| Biological Transport, Active | 1 | 1989 | 76 | 0.000 |
Why?
|
| Obesity | 1 | 1997 | 2391 | 0.000 |
Why?
|
| Adolescent | 1 | 2004 | 20562 | 0.000 |
Why?
|